Found: 7
Select item for more details and to access through your institution.
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01046-2
- By:
- Publication type:
- Article
Potential value of pre-planned imaging of bone disease in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00880-0
- By:
- Publication type:
- Article
Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. E73, doi. 10.1002/ajh.23932
- By:
- Publication type:
- Article
Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 575, doi. 10.1002/ajh.23688
- By:
- Publication type:
- Article
Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.
- Published in:
- Quality of Life Research, 2024, v. 33, n. 9, p. 2387, doi. 10.1007/s11136-024-03707-y
- By:
- Publication type:
- Article
Strategies to improve patient-reported outcome completion rates in longitudinal studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article